73 related articles for article (PubMed ID: 15732722)
1. [Use of meloxicam (movalis) in patients with rheumatic diseases with concomitant coronary heart disease].
Mazurov VI; Iakusheva VA; Beliaeva IB
Klin Med (Mosk); 2004; 82(12):54-9. PubMed ID: 15732722
[TBL] [Abstract][Full Text] [Related]
2. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
Combe B; Vélicitat P; Garzón N; Bluhmki E
Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
[TBL] [Abstract][Full Text] [Related]
3. [Use of movalis in treatment of dorsopathy].
Odinak MM; Emelin AIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):29-32. PubMed ID: 15847323
[TBL] [Abstract][Full Text] [Related]
4. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac.
Furst DE; Kolba KS; Fleischmann R; Silverfield J; Greenwald M; Roth S; Hall DB; Roszko PJ;
J Rheumatol; 2002 Mar; 29(3):436-46. PubMed ID: 11908554
[TBL] [Abstract][Full Text] [Related]
5. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
[TBL] [Abstract][Full Text] [Related]
6. [The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease].
Zunnunov ZR
Ter Arkh; 2010; 82(1):24-7. PubMed ID: 20364695
[TBL] [Abstract][Full Text] [Related]
7. [Safety and efficacy of movalis injected into trigger points in lumbago-ischialgia syndrome].
Shirokov VA; Potaturko AV; Zakharov IaIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(9):41-4. PubMed ID: 18833170
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
Ruperto N; Nikishina I; Pachanov ED; Shachbazian Y; Prieur AM; Mouy R; Joos R; Zulian F; Schwarz R; Artamonova V; Emminger W; Bandeira M; Buoncompagni A; Foeldvari I; Falcini F; Baildam E; Kone-Paut I; Alessio M; Gerloni V; Lenhardt A; Martini A; Hanft G; Sigmund R; Simianer S;
Arthritis Rheum; 2005 Feb; 52(2):563-72. PubMed ID: 15692986
[TBL] [Abstract][Full Text] [Related]
9. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
[TBL] [Abstract][Full Text] [Related]
10. [Meloxicam (Movalis)].
Kaliterna DM
Reumatizam; 2007; 54(2):81-2. PubMed ID: 18351150
[No Abstract] [Full Text] [Related]
11. [Meloxicam: intramuscular administration in rheumatology].
Tsvetkova ES
Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
[No Abstract] [Full Text] [Related]
12. [Efficacy of movalis in the treatment of acute low back pains].
Filatova EG; Kondrikov AV; Istomina OI
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):33-7. PubMed ID: 16117144
[TBL] [Abstract][Full Text] [Related]
13. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
[No Abstract] [Full Text] [Related]
14. Resting electrocardiogram and risk of coronary heart disease in middle-aged British men.
Whincup PH; Wannamethee G; Macfarlane PW; Walker M; Shaper AG
J Cardiovasc Risk; 1995 Dec; 2(6):533-43. PubMed ID: 8665372
[TBL] [Abstract][Full Text] [Related]
15. [The clinical and functional evaluation of cardiac electrical instability in patients with silent myocardial ischemia].
Tatarchenko IP; Pozdniakova NV; Morozova OI; Zaĭtseva AV
Ter Arkh; 2010; 82(4):22-7. PubMed ID: 20481210
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory and endothelium protective effect of long-term pioglitazone intake in patients suffering from bronchial asthma concurrent with ischemic heart disease.
Byelan OV; Mamontova TV; Vesnina LE; Borzykh OA; Kaidashev IP
Wiad Lek; 2017; 70(4):712-720. PubMed ID: 29064792
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease.
Wisłowska M; Sypuła S; Kowalik I
Clin Rheumatol; 1998; 17(5):369-77. PubMed ID: 9805180
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
Degner F; Sigmund R; Zeidler H
Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
[TBL] [Abstract][Full Text] [Related]
19. [First i.m., now oral. COX-2 inhibitor in acute lumbago].
MMW Fortschr Med; 2002 Nov; 144(47):66. PubMed ID: 12532533
[No Abstract] [Full Text] [Related]
20. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
